Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival

Overview of attention for article published in Annals of Surgical Oncology, June 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 5 X users

Readers on

mendeley: 80 Mendeley

Summary X

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 10,757 followers.

@manjuggm @pashtoonkasi @OncoAlert @NateraOncology @AGangiMD @agrothey @GIcancerDoc @DocCatenacci @DrKelseyKlute @ShaalanBeg @aparna1024 https://t.co/jyBZDhgHDT shows 30% ctDNA detection rate in peritoneal mets

09 Dec 2020

Reply Repost Favourite

RT @Dr_R_Kurzrock: Preoperative ctDNA in Peritoneal Carcinomatosis IPredicts Progression-Free Survival. Annals of Surgical Oncology https…

06 Sep 2018

Reply Repost Favourite

Preoperative ctDNA in Peritoneal Carcinomatosis IPredicts Progression-Free Survival. Annals of Surgical Oncology https://t.co/bCzBByMtsT

06 Sep 2018

Reply Repost Favourite

Preoperative Circulating Tumor in Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival https://t.co/coZhq1ssTj

30 Jun 2018

Reply Repost Favourite

Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival. https://t.co/XYN8moEAuC

28 Jun 2018

Reply Repost Favourite

PubMed_ Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival. https://t.co/XWSt318iXS

28 Jun 2018

Reply Repost Favourite